NCT06958276

Brief Summary

CrossFit is a high-intensity physical training program that combines exercises from various disciplines, such as weightlifting, track and field, running, and gymnastics. The three main characteristics of this sport discipline are as follows: first, the execution of functional movements; second, performing them at high intensity; and lastly, constant variation. This training model has shown improvements in strength, power, balance, flexibility, and cardiorespiratory capacities. There are various risk factors described in the literature that may lead to injuries in CrossFit athletes. It has been suggested that demanding training programs increase this risk, especially when performed incorrectly (poor technique). Additionally, excessive training load and frequency can lead to early fatigue, greater perceived effort, and risky movement execution. On the other hand, older age, male sex, and previous injuries also appear to be relevant risk factors, as well as performing stretches prior to CrossFit practice. Several studies have shown that the shoulder is the joint with the highest prevalence of injury in this sport, surpassing other commonly affected joints such as the lumbar spine or the knee. Among the wide variety of injuries related to the shoulder, the diagnosis of "nonspecific shoulder pain" has a high prevalence in the adult population. This term is used to describe clinical cases where it is not possible to identify the specific cause of the pain, and is justified by its multifactorial etiology, which is associated with several risk factors. These include: imbalance in the strength ratio between internal and external rotators, limitations in rotational mobility of the glenohumeral joint, deficits in motor control of the scapular musculature, shoulder muscle fatigue, and the repetitive execution of overhead exercises. This last factor is especially relevant in the CrossFit population, as such movements are frequent in the discipline. Repeated overhead exercises have been associated with a deficit in glenohumeral internal rotation. From a biomechanical perspective, this movement is more efficient when accompanied by external rotation, so internal rotation limitation can compromise the motion. This deficit has been linked to modifiable musculoskeletal factors such as posterior capsule stiffness, shortening of the infraspinatus or teres minor muscles, and scapular mechanics alterations, as well as non-modifiable factors like bone torsion observed in young athletes. These conditions can lead to pain and/or glenoid labrum pathology. Regarding the clinical management of nonspecific shoulder pain, conservative physiotherapy treatment is the most common approach. This is based on manual therapy and therapeutic exercise. However, in recent years, invasive physiotherapy has gained popularity in the treatment of musculoskeletal disorders through techniques such as ultrasound-guided percutaneous neuromodulation (US-guided PNM). This technique involves delivering electrical stimulation through an acupuncture needle placed near the nerve (epineurium) or the motor point of the target muscle, aiming to restore proper functionality of pathological neuromuscular structures. US-guided PNM, applied to both the lower and upper limbs, has shown effectiveness in both healthy individuals and subjects with various musculoskeletal disorders, improving pain, strength, flexibility, and normalization of neural excitability. Currently, there are therapeutic exercise protocols used for both evaluation and treatment of nonspecific shoulder pain in CrossFit athletes. Additionally, there are US-guided PNM protocols that have been applied to healthy CrossFit athletes and have demonstrated improvements in shoulder rotational strength. However, US-guided PNM has not yet been studied in a population of CrossFit athletes with nonspecific shoulder pain. Therefore, this randomized clinical trial aims to evaluate the effectiveness of two different US-guided PNM protocols, analyzing which methodology is most appropriate for reducing the risk factors associated with the development of nonspecific shoulder pain in CrossFit athletes.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
42

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 19, 2025

Completed
12 days until next milestone

Study Start

First participant enrolled

May 1, 2025

Completed
5 days until next milestone

First Posted

Study publicly available on registry

May 6, 2025

Completed
26 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2025

Completed
Last Updated

September 2, 2025

Status Verified

August 1, 2025

Enrollment Period

1 month

First QC Date

April 19, 2025

Last Update Submit

August 25, 2025

Conditions

Keywords

neuromodulationpercutaneousultrasoundaxillary nervesuprascapular nerve

Outcome Measures

Primary Outcomes (1)

  • Strength ratio between ER/IR

    A hand-held dynamometer (HHD) with units in kg of force (KgF) was used. The participant was positioned according to the instructions of Hams et al., seated with the hip and knee flexed at 90 degrees, feet flat on the floor, trunk upright, shoulder at 0 degrees of abduction and neutral rotation, and elbow in contact with the trunk, flexed at 90 degrees. The dynamometer was placed on the distal third of the inner forearm to assess internal rotation (IR) and on the distal third of the outer forearm to assess external rotation (ER). Athletes were instructed to produce the maximum isometric force for 10 seconds, while the evaluator applied the same force in the opposite direction. Three tests were performed bilaterally, with a one-minute rest between each test, and the final data was the average of the three tests. The strength ratio was calculated by dividing ER/IR, with 2:3 (0.66) considered the ideal ratio.

    The measurements were taken pre-intervention and immediately post-intervention.

Secondary Outcomes (2)

  • Glenohumeral rotational mobility

    The measurements were taken pre-intervention and immediately post-intervention.

  • Scapular motor control

    The measurements were taken pre-intervention and immediately post-intervention.

Study Arms (2)

US-guided PNM 10 Hz

EXPERIMENTAL

One session of US-guided PNM at a frequency of 10 Hz.

Other: Ultrasound Guided Percutaneous Neuromodulation. Frequency of 10 Hz

US-guided PNM 1 Hz

EXPERIMENTAL

One session of US-guided PNM at a frequency of 1 Hz.

Other: Ultrasound Guided Percutaneous Neuromodulación. Frequency of 1 Hz

Interventions

The US-guided PNM intervention will be performed with the patient in the prone position, the shoulder to be treated flexed at 90 degrees, the humerus partially supported on the table, the elbow flexed at 90 degrees, and the musculature relaxed. Needles will be inserted near the perineurium of the axillary and suprascapular nerves. Prior to needle insertion, the skin will be cleaned with isopropyl alcohol and chlorhexidine. The PNM intervention will consist of applying a compensated asymmetric biphasic current, with a rectangular positive phase and a triangular negative phase, at a frequency of 10 Hz, pulse width of 240 μs, and the maximum tolerated intensity that elicits a painless maximal muscle contraction, following this protocol: 10 stimulations of 10 seconds each, with a 10-second rest between stimulations.

US-guided PNM 10 Hz

Same intervention as previously described, with the only difference being that the frequency will be 1 Hz instead of 10 Hz.

US-guided PNM 1 Hz

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Be over 18 years old.
  • Have shoulder pain lasting more than 3 months.
  • The pain must not have an apparent cause, meaning there is no specific diagnosis, and thus it is considered nonspecific pain.
  • Train CrossFit at least 3 days per week.

You may not qualify if:

  • Have received any medical or physiotherapy treatment for nonspecific shoulder pain.
  • Have had previous shoulder surgery.
  • Present fear of needles (belonephobia) or fear of the US-guided PNM intervention.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Zaragoza

Zaragoza, Zaragoza, 50009, Spain

Location

Study Officials

  • Alberto Carcasona, Physiotherapist

    IIS Aragón, University of Zaragoza

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
The participant will not be aware of which type of intervention they are receiving, as both interventions involve the application of a single session of US-guided PNM. The only difference between groups lies in the stimulation frequency: 10 Hz for one group and 1 Hz for the other, making it indistinguishable for the participant. Additionally, the evaluator will be different from the researcher responsible for administering the interventions and will therefore also be blinded to the type of intervention each participant has received.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

April 19, 2025

First Posted

May 6, 2025

Study Start

May 1, 2025

Primary Completion

June 1, 2025

Study Completion

July 31, 2025

Last Updated

September 2, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will share

Data will be shared on a reasonable request contacting with the main author once data has been published. Anyway, Individual participant data (IPD) will be shared with other researchers in accordance with data sharing protocols and participant consent, ensuring confidentiality and ethical considerations are maintained.

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
Once research has been published
Access Criteria
Study protocol will be publish in a scientific journal

Locations